Home > Insider Trading > Filing (0001209191-10-058457)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
858803	Avanir Pharmaceuticals Inc.	AVNR	Pharmaceutical Preparations (2834)	330314804

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1314596	Keith Katkin	101 Enterprise, Suite 300 Aliso Viejo CA 92656	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2010-12-01	62,500	$0.00	208,352	No	4	A	Direct
Common Stock	Acquisiton	2010-12-02	195,300	$0.53	403,652	No	4	M	Direct
Common Stock	Disposition	2010-12-02	195,300	$4.08	208,352	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2010-12-01	400,000	$0.00	400,000	$4.18
Common Stock	Stock Option (right to buy)	Disposition	2010-12-02	195,300	$0.00	195,300	$0.53

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
400,000		2020-12-01	No	4	A	Direct
251,100		2018-12-16	No	4	M	Direct

Footnotes

Represents shares underlying Restricted Stock Units granted under the Issuer's 2005 Equity Incentive Plan that vest upon the satisfaction of certain performance milestones as follows: 50% of the underlying shares shall vest one year from achievement of the milestones and the remaining 50% of the underlying shares shall vest two years from achievement of the milestones.
Not applicable.
Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting Person, which are subject to certain vesting conditions.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.03 to $4.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The option shall vest with respect to one-quarter of the underlying shares upon the first anniversary of December 1, 2010, and then with respect to the remaining shares quarterly thereafter over the next three years.
The option vests with respect to one-quarter of the underlying shares upon the first anniversary of December 16, 2008, and then with respect to the remaining shares quarterly thereafter over the next three years.